Drug Trial Radar · NCT05879614
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
Last checked: Nov 20, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Sep 1, 2023
Primary completion
Jun 30, 2025
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- Neuren Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- First posted
- May 30, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Prader-Willi Syndrome.
Conditions
- Prader-Willi Syndrome
Interventions
NNZ-2591Drug
NNZ-2591 oral solution (50mg/mL) to be administered twice daily for 13 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and TolerabilityTime frame: 13 weeks
- Pharmacokinetic - Measurement of CmaxTime frame: 13 weeks
- Pharmacokinetic - Measurement of AUCTime frame: 13 weeks
- Pharmacokinetic - Measurement of time to CmaxTime frame: 13 weeks
- Pharmacokinetic - Measurement of t1/2Time frame: 13 weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Rady Children's Hospital San Diego
San Diego, California
Rare Disease Research
Atlanta, Georgia
Uncommon Cures
Chevy Chase, Maryland
Suburban Research
Media, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.